Overview

V+PSF-M for Tobacco Cessation in HIV Care in India

Status:
Not yet recruiting
Trial end date:
2025-07-20
Target enrollment:
Participant gender:
Summary
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: - Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) - Varenicline (or Chantix)
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Cancer Institute (NCI)
Treatments:
Varenicline